Biochemical Characterization of a New 10% IVIG Preparation [IgG Next Generation (BT595)/Yimmugo(®)] Obtained from a Manufacturing Process Preserving IgA/IgM Potential of Human Plasma

BACKGROUND AND OBJECTIVE: Human plasma is used for the generation of several life-saving drugs and contains valuable antibodies from the immunoglobulin classes IgG, IgM and IgA. Purified intravenous IgG solutions (IVIGs) form the majority of plasma-derived medicine to treat patients with various for...

Descripción completa

Detalles Bibliográficos
Autores principales: Duellberg, Christian, Hannappel, Achim, Kistner, Steffen, Maneg, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439088/
https://www.ncbi.nlm.nih.gov/pubmed/37466834
http://dx.doi.org/10.1007/s40268-023-00430-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439088/
https://www.ncbi.nlm.nih.gov/pubmed/37466834
http://dx.doi.org/10.1007/s40268-023-00430-w

Ejemplares similares